捕获帕金无化酶的催化中间体
Elizabeth M Connelly1, Anne C Rintala-Dempsey1, Mehmet Gundogdu2
1Department of Biochemistry, The University of Western Ontario, London, ON N6A 5C1, Canada.
概括
研究人员确定了parkin的催化中间体,一种与帕金森病相关的E3泛素联酶. 这一发现揭示了parkin如何识别ubiquitin,为疾病机制和潜在的治疗点提供了洞察力.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 神经科学是一个神经科学.
背景情况:
- 帕金是E3泛基因酶,对线粒代谢至关重要,并与早期发病的帕金森病有关.
- 了解帕金森的催化机制,特别是中介的平静化,对于开发帕金森症治疗方法至关重要.
- 帕金催化域对乌比奎的识别的精确机制以及化复合体的结构仍然未确定.
研究的目的:
- 阐明帕金催化剂中间体的结构和机制细节.
- 在帕金的催化域内识别无处不在的识别动机.
- 为了解帕金森相关突变如何影响帕金森活动提供见解.
主要方法:
- 基于核磁共振 (NMR) 的化学转移扰动实验,以确定Rcat-ubiquitin复合物的结构.
- 导向的AlphaFold建模,化学交叉链接和单个周转试验,以建模全长的帕金静脉复合体.
- 生物化学分析验证结构模型并评估突变的影响.
主要成果:
- 捕获了与ubiquitin (Rcat-Ub) 复合的parkin的Rcat域的催化中间体,并确定了它的结构.
- 在Rcat域附近的一个新型α螺旋区域被确定为ubiquitin识别动机,引导ubiquitin到催化部位.
- 建立了一种经过验证的全长parkin模型,在 transthiolation中介复合物中与UbcH7,ubiquitin和phosphoubiquitin一起建立.
- 这些结构发现解释了帕金氏体T415N突变的致病机制.
结论:
- 鉴定了帕金催化中间体和乌比奎的方向,为E3结合酶功能提供了关键的结构洞察力.
- 这项工作阐明了parkin转移泛素的机制及其在帕金森病发病过程中的作用.
- 这些发现为基于结构的药物设计铺平了道路,针对帕金森氏症治疗.
更多相关视频
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
7.5K
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.1K
相关概念视频
02:04Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
01:13The Proteasome
822
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
822
02:58Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
01:17The Proteasome Structure
723
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
723